Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma. | Sci Rep | 2022 | 36335135 | PubTator, text mining | PubMed |
| Deep transfer learning of cancer drug responses by integrating bulk and single-cell RNA-seq data. | Nat Commun | 2022 | 36310235 | PubTator, text mining | PubMed |
| The multiple de novo copy number variant (MdnCNV) phenomenon presents with peri-zygotic DNA mutational signatures and multilocus pathogenic variation. | Genome Med | 2022 | 36303224 | PubTator, text mining | PubMed |
| The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer. | Life (Basel) | 2022 | 36294987 | PubTator, text mining | PubMed |
| Molecular Epidemiology in Amerindians of the Brazilian Amazon Reveals New Genetic Variants in DNA Repair Genes. | Genes (Basel) | 2022 | 36292754 | PubTator, text mining | PubMed |
| Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability. | Cancers (Basel) | 2022 | 36291761 | PubTator, text mining | PubMed |
| Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis. | Biomolecules | 2022 | 36291559 | PubTator, text mining | PubMed |
| An MSH6 germline pathogenic variant p.Gly162Ter associated with Lynch syndrome. | Hum Genome Var | 2022 | 36289196 | PubTator, text mining | PubMed |
| Left-sided colorectal cancer distinct in indigenous African patients compared to other ethnic groups in South Africa. | BMC Cancer | 2022 | 36280820 | PubTator, text mining | PubMed |
| Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma. | Front Immunol | 2022 | 36275690 | PubTator, text mining | PubMed |
Individualized combination therapies based on whole-exome sequencing displayed significant clinical benefits in a glioblastoma patient with secondary osteosarcoma: case report and genetic characterization. | BMC Neurol | 2022 | 36271359 | PubTator, text mining | PubMed |
| Mismatch repair deficiency in rectal cancer: an evolving scenario. | Ann Transl Med | 2022 | 36267787 | PubTator, text mining | PubMed |
| Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. | Cancer Commun (Lond) | 2022 | 36264285 | PubTator, text mining | PubMed |
HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs. | Oncotarget | 2022 | 36243940 | PubTator, text mining | PubMed |
| Genetic map of regional sulcal morphology in the human brain from UK biobank data. | Nat Commun | 2022 | 36241887 | PubTator, text mining | PubMed |
| Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data. | Int J Mol Sci | 2022 | 36232764 | PubTator, text mining | PubMed |
| Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors. | Cancers (Basel) | 2022 | 36230726 | PubTator, text mining | PubMed |
| Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer. | Cancers (Basel) | 2022 | 36230592 | PubTator, text mining | PubMed |
| Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods. | Cancers (Basel) | 2022 | 36230473 | PubTator, text mining | PubMed |
| High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway. | Oxid Med Cell Longev | 2022 | 36211828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=26